Bridgepoint Group Plc (BPT)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 392.20 |
|---|---|
| 52-week range | 212.00 – 416.20 |
| Return, 1 month / 3 months | +26.8% / +26.6% |
| Return, 1 year / 3 years | +33.8% / +143.6% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 40.1% |
| Worst drawdown (1 year) | -28.4% |
| Average daily value traded | 590.98M GBX |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bridgepoint Group is a private markets investment firm based in London. It raises and manages funds that invest in mid-market companies, mainly through private equity, and it also runs private credit strategies. Its investors include institutional clients such as pension funds and other long-term investors, and its portfolio companies operate across a range of sectors in Europe and beyond. The firm earns fees for managing these funds and for advising the businesses it backs.
The shares are listed on the London Exchange in UK under the code BPT, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bridgepoint Group Plc (BPT) trades on the London Exchange in UK. It last closed at GBX 392.20 on 23 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 329 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.8% and over the last three months it rose 26.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 40.5% | ||
| From 52-week high | -4.8% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 26.6% | ||
| 6-month return | 48.6% | ||
| 12-month return, skipping the last month | 5.6% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.4% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 590.98M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | +26.8% |
| 3 months | +26.6% |
| 6 months | +48.6% |
| 1 year | +33.8% |
| 3 years | +143.6% |
| 5 years | −1.0% |
Signals
| 50-day / 200-day average | 332.59 / 279.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 16.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Oct 2026 | GBP 0.0500 |
| 17 Sep 2026 | GBP 0.0480 |
| 23 Apr 2026 | GBP 0.0470 |
| 18 Sep 2025 | GBP 0.0470 |
| 24 Apr 2025 | GBP 0.0460 |
| 19 Sep 2024 | GBP 0.0460 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.